These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 20519504)

  • 1. Muscleblind-like 1 (Mbnl1) promotes insulin receptor exon 11 inclusion via binding to a downstream evolutionarily conserved intronic enhancer.
    Sen S; Talukdar I; Liu Y; Tam J; Reddy S; Webster NJ
    J Biol Chem; 2010 Aug; 285(33):25426-37. PubMed ID: 20519504
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SRp20 and CUG-BP1 modulate insulin receptor exon 11 alternative splicing.
    Sen S; Talukdar I; Webster NJ
    Mol Cell Biol; 2009 Feb; 29(3):871-80. PubMed ID: 19047369
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Muscleblind-like 1 activates insulin receptor exon 11 inclusion by enhancing U2AF65 binding and splicing of the upstream intron.
    Echeverria GV; Cooper TA
    Nucleic Acids Res; 2014 Feb; 42(3):1893-903. PubMed ID: 24185704
    [TBL] [Abstract][Full Text] [Related]  

  • 4. hnRNP A1 and hnRNP F modulate the alternative splicing of exon 11 of the insulin receptor gene.
    Talukdar I; Sen S; Urbano R; Thompson J; Yates JR; Webster NJ
    PLoS One; 2011; 6(11):e27869. PubMed ID: 22132154
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The CD44 alternative v9 exon contains a splicing enhancer responsive to the SR proteins 9G8, ASF/SF2, and SRp20.
    Galiana-Arnoux D; Lejeune F; Gesnel MC; Stevenin J; Breathnach R; Del Gatto-Konczak F
    J Biol Chem; 2003 Aug; 278(35):32943-53. PubMed ID: 12826680
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of MBNL1 and MBNL3 domains required for splicing activation and repression.
    Grammatikakis I; Goo YH; Echeverria GV; Cooper TA
    Nucleic Acids Res; 2011 Apr; 39(7):2769-80. PubMed ID: 21109529
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of intron and exon sequences involved in alternative splicing of insulin receptor pre-mRNA.
    Kosaki A; Nelson J; Webster NJ
    J Biol Chem; 1998 Apr; 273(17):10331-7. PubMed ID: 9553088
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autoregulated splicing of muscleblind-like 1 (MBNL1) Pre-mRNA.
    Gates DP; Coonrod LA; Berglund JA
    J Biol Chem; 2011 Sep; 286(39):34224-33. PubMed ID: 21832083
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MBNL1 is the primary determinant of focus formation and aberrant insulin receptor splicing in DM1.
    Dansithong W; Paul S; Comai L; Reddy S
    J Biol Chem; 2005 Feb; 280(7):5773-80. PubMed ID: 15546872
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Conserved developmental alternative splicing of muscleblind-like (MBNL) transcripts regulates MBNL localization and activity.
    Terenzi F; Ladd AN
    RNA Biol; 2010; 7(1):43-55. PubMed ID: 20009516
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alternative splicing of the neurofibromatosis type 1 pre-mRNA is regulated by the muscleblind-like proteins and the CUG-BP and ELAV-like factors.
    Fleming VA; Geng C; Ladd AN; Lou H
    BMC Mol Biol; 2012 Dec; 13():35. PubMed ID: 23227900
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The deep intronic c.903+469T>C mutation in the MTRR gene creates an SF2/ASF binding exonic splicing enhancer, which leads to pseudoexon activation and causes the cblE type of homocystinuria.
    Homolova K; Zavadakova P; Doktor TK; Schroeder LD; Kozich V; Andresen BS
    Hum Mutat; 2010 Apr; 31(4):437-44. PubMed ID: 20120036
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel intronic cis element, ISE/ISS-3, regulates rat fibroblast growth factor receptor 2 splicing through activation of an upstream exon and repression of a downstream exon containing a noncanonical branch point sequence.
    Hovhannisyan RH; Carstens RP
    Mol Cell Biol; 2005 Jan; 25(1):250-63. PubMed ID: 15601847
    [TBL] [Abstract][Full Text] [Related]  

  • 14. hnRNP A1 and the SR proteins ASF/SF2 and SC35 have antagonistic functions in splicing of beta-tropomyosin exon 6B.
    Expert-Bezançon A; Sureau A; Durosay P; Salesse R; Groeneveld H; Lecaer JP; Marie J
    J Biol Chem; 2004 Sep; 279(37):38249-59. PubMed ID: 15208309
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The CELF family of RNA binding proteins is implicated in cell-specific and developmentally regulated alternative splicing.
    Ladd AN; Charlet N; Cooper TA
    Mol Cell Biol; 2001 Feb; 21(4):1285-96. PubMed ID: 11158314
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interaction of muscleblind, CUG-BP1 and hnRNP H proteins in DM1-associated aberrant IR splicing.
    Paul S; Dansithong W; Kim D; Rossi J; Webster NJ; Comai L; Reddy S
    EMBO J; 2006 Sep; 25(18):4271-83. PubMed ID: 16946708
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nova regulates GABA(A) receptor gamma2 alternative splicing via a distal downstream UCAU-rich intronic splicing enhancer.
    Dredge BK; Darnell RB
    Mol Cell Biol; 2003 Jul; 23(13):4687-700. PubMed ID: 12808107
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Depletion of TDP 43 overrides the need for exonic and intronic splicing enhancers in the human apoA-II gene.
    Mercado PA; Ayala YM; Romano M; Buratti E; Baralle FE
    Nucleic Acids Res; 2005; 33(18):6000-10. PubMed ID: 16254078
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combinatorial control of a neuron-specific exon.
    Modafferi EF; Black DL
    RNA; 1999 May; 5(5):687-706. PubMed ID: 10334339
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interaction of hnRNPA1/A2 and DAZAP1 with an Alu-derived intronic splicing enhancer regulates ATM aberrant splicing.
    Pastor T; Pagani F
    PLoS One; 2011; 6(8):e23349. PubMed ID: 21858080
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.